Across TCGA pan-cancer cohorts, WDR97 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated WDR97 data layer compared with 20 for mass-spec protein.
The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher WDR97 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated WDR97 expression acts as an unfavorable survival marker.
CESC and UCEC are the cancer types where WDR97 Mutation most reproducibly stratifies survival.